{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T09:14:05Z","timestamp":1782983645967,"version":"3.54.5"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T00:00:00Z","timestamp":1347926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Fungal Infect Rep"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12281-012-0105-y","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T07:05:39Z","timestamp":1347865539000},"page":"235-244","source":"Crossref","is-referenced-by-count":21,"title":["Progress Toward a Human Vaccine Against Coccidioidomycosis"],"prefix":"10.1007","volume":"6","author":[{"given":"Garry T.","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brady J.","family":"Hurtgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Yu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,18]]},"reference":[{"key":"105_CR1","unstructured":"Centers for Disease Control and Prevention (CDC). Increase in coccidioidomycosis - California, 2000-2007. MMWR Morb Mortal Wkly Rep. 2009;58:105\u2013109."},{"key":"105_CR2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.rmed.2012.02.004","volume":"106","author":"CA Hage","year":"2012","unstructured":"Hage CA, Knox KS, Wheat LJ. Endemic mycoses: overlooked causes of community acquired pneumonia. Resp Med. 2012;106:769\u201376.","journal-title":"Resp Med"},{"key":"105_CR3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1399-3062.2011.00698.x","volume":"14","author":"E Blodget","year":"2012","unstructured":"\u2022 Blodget E, Jan Geiseler P, Larsen RA, Stapfer M, Qazi Y, Petrovic LM. Donor-derived Coccidioides immitis fungemia in solid organ transplant recipients. Transpl Infect Dis. 2012;14:305\u201310. This paper reports the risk of coccidioidomycosis in SOT among patients who receive an organ from a donor in the endemic regions and illustrates the need for diagnostic evaluation.","journal-title":"Transpl Infect Dis"},{"key":"105_CR4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1399-3062.2011.00696.x","volume":"14","author":"KL Dierberg","year":"2012","unstructured":"Dierberg KL, Marr KA, Subramanian A, Nace H, Desai N, Locke JE, et al. Donor-derived organ transplant transmission of coccidioidomycosis. Transpl Infect Dis. 2012;14:300\u20134.","journal-title":"Transpl Infect Dis"},{"key":"105_CR5","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/j.1600-6143.2012.04100.x","volume":"12","author":"N Singh","year":"2012","unstructured":"Singh N, Huprikar S, Burdette SD, Morris MI, Blair JE, Wheat LJ, et al. Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice. Am J Transplant. 2012;12:2414\u201328.","journal-title":"Am J Transplant"},{"key":"105_CR6","first-page":"356","volume-title":"Medical mycology","author":"KJ Kwon-Chung","year":"1992","unstructured":"Kwon-Chung KJ, Bennett JE. Medical mycology. Malvern: Lea & Febiger; 1992. p. 356\u201396."},{"key":"105_CR7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4612-3730-3_6","volume":"2","author":"D Pappagianis","year":"1988","unstructured":"Pappagianis D. Epidemiology of coccidioidomycosis. Curr Topics Med Mycol. 1988;2:199\u2013238.","journal-title":"Curr Topics Med Mycol"},{"key":"105_CR8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1708-8305.2012.00599.x","volume":"19","author":"F Gobbi","year":"2012","unstructured":"\u2022 Gobbi F, Angheben A, Farina C, Buonfrate D, Postiglione C, Rossanese A, et al. Coccidioidomycosis: first imported case in Italy. J Travel Med. 2012;19:192\u20134. This paper illustrates the need for physicians to consider coccidioidomycosis in their differential diagnosis of febrile patients who have resided even for a short period in a Coccidioides endemic region, especially if they present with hypereosinophilia.","journal-title":"J Travel Med"},{"key":"105_CR9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1196\/annals.1406.045","volume":"1111","author":"RH Sunenshine","year":"2007","unstructured":"Sunenshine RH, Anderson S, Erhart L, Vossbrink A, Kelly PC, Engelthaler D, et al. Public health surveillance for coccidioidomycosis in Arizona. Ann N Y Acad Sci. 2007;1111:96\u2013102.","journal-title":"Ann N Y Acad Sci"},{"key":"105_CR10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3201\/eid1503.081007","volume":"15","author":"MM Kim","year":"2009","unstructured":"Kim MM, Blair JE, Carey EJ, Wu Q, Smilack JD. Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000-2004. Emerg Infect Dis. 2009;15:397\u2013401.","journal-title":"Emerg Infect Dis"},{"key":"105_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1513\/pats.200907-080AL","volume":"7","author":"NM Ampel","year":"2010","unstructured":"Ampel NM. New perspectives on coccidioidomycosis. Proc Am Thorac Soc. 2010;7:181\u20135.","journal-title":"Proc Am Thorac Soc"},{"key":"105_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1196\/annals.1406.004","volume":"1111","author":"R Laniado-Laborin","year":"2007","unstructured":"Laniado-Laborin R. Expanding understanding of epidemiology of coccidioidomycosis in the Western Hemisphere. Ann N Y Acad Sci. 2007;1111:19\u201334.","journal-title":"Ann N Y Acad Sci"},{"key":"105_CR13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1001\/jama.1979.03300150029022","volume":"242","author":"D Fraser","year":"1979","unstructured":"Fraser D, Ward JI, Ajello L, Plikaytis BD. Aspergillosis and other systemic mycoses: the growing problem. JAMA. 1979;242:1631\u20135.","journal-title":"JAMA"},{"key":"105_CR14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1086\/593192","volume":"47","author":"JE Blair","year":"2008","unstructured":"Blair JE, Mayer AP, Currier J, Files JA, Wu Q. Coccidioidomycosis in elderly persons. Clin Infect Dis. 2008;47:1513\u20138.","journal-title":"Clin Infect Dis"},{"key":"105_CR15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1196\/annals.1406.001","volume":"1111","author":"NF Crum-Cianflone","year":"2007","unstructured":"Crum-Cianflone NF. Coccidioidomycosis in the U.S. military. Ann N Y Acad Sci. 2007;1111:112\u201321.","journal-title":"Ann N Y Acad Sci"},{"key":"105_CR16","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3201\/eid1709.101987","volume":"17","author":"JW Baddley","year":"2011","unstructured":"Baddley JW, Winthrop KL, Patkar NM, Delzell E, Beukelman T, Xie F, et al. Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis. 2011;17:1664\u20139.","journal-title":"Emerg Infect Dis"},{"key":"105_CR17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1130-1406(07)70022-0","volume":"24","author":"RC Baptista Rosas","year":"2007","unstructured":"Baptista Rosas RC, Riquelme M. The epidemiology of coccidioidomycosis in Mexico. Rev Iberoam Micol. 2007;24:100\u20135.","journal-title":"Rev Iberoam Micol"},{"key":"105_CR18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12281-011-0081-7","volume":"6","author":"J Sifuentes-Osornio","year":"2012","unstructured":"\u2022 Sifuentes-Osornio J, Corzo-Leon DE, Ponce-de-Leon LA. Epidemiology of invasive fungal infections in Latin America. Curr Fungal Infect Rep. 2012;6:23\u201334. This paper provides an update on the geographic location of endemic regions of Coccidioides as well as other dimorphic fungal pathogens in Central and South America.","journal-title":"Curr Fungal Infect Rep"},{"key":"105_CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/314835","volume":"180","author":"D Pappagianis","year":"1999","unstructured":"Pappagianis D. Coccidioides immitis antigen. J Infect Dis. 1999;180:243\u20134.","journal-title":"J Infect Dis"},{"key":"105_CR20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-2008-1063855","volume":"29","author":"IM Spinello","year":"2008","unstructured":"Spinello IM, Munoz A, Johnson RH. Pulmonary coccidioidomycosis. Semin Respir Crit Care Med. 2008;29:166\u201373.","journal-title":"Semin Respir Crit Care Med"},{"key":"105_CR21","first-page":"603","volume":"68","author":"GT Cole","year":"2002","unstructured":"Cole GT, Hung CY, Delgado N. Parasitic phase-specific gene expression in Coccidioides. ASM News. 2002;68:603\u201311.","journal-title":"ASM News"},{"key":"105_CR22","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/JB.72.6.784-792.1956","volume":"72","author":"JL Converse","year":"1956","unstructured":"Converse JL. Effect of physico-chemical environment of spherulation of Coccidioides immitis in a chemically defined medium. J Bacteriol. 1956;72:784\u201392.","journal-title":"J Bacteriol"},{"key":"105_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02051493","volume":"41","author":"HB Levine","year":"1970","unstructured":"Levine HB, Pappagianis D, Cobb JM. Development of vaccines for coccidioidomycosis. Mycopath Mycol Appl. 1970;41:177\u201385.","journal-title":"Mycopath Mycol Appl"},{"key":"105_CR24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1164\/ajrccm\/148.3.656","volume":"148","author":"D Pappagianis","year":"1993","unstructured":"Pappagianis D. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group. Am Rev Respir Dis. 1993;148:656\u201360.","journal-title":"Am Rev Respir Dis"},{"key":"105_CR25","doi-asserted-by":"crossref","unstructured":"Liu M, Clemons KV, Johansen ME, Martinez M, Chen V, Stevens DA. Saccharomyces as a vaccine against systemic candidiasis. Immunol Invest. 2012. doi: 10.3109\/08820139.2012.692418 .","DOI":"10.3109\/08820139.2012.692418"},{"issue":"Suppl 1","key":"105_CR26","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.3109\/13693786.2010.497775","volume":"49","author":"DA Stevens","year":"2011","unstructured":"Stevens DA, Clemons KV, Liu M. Developing a vaccine against aspergillosis. Med Mycol. 2011;49 Suppl 1:S170\u20136.","journal-title":"Med Mycol"},{"key":"105_CR27","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1016\/j.vaccine.2009.03.030","volume":"27","author":"J Capilla","year":"2009","unstructured":"\u2022\u2022 Capilla J, Clemons KV, Liu M, Levine HB, Stevens DA. Saccharomyces cerevisiae as a vaccine against coccidioidomycosis. Vaccine. 2009;27:3662\u20138. The authors present an argument for the protective efficacy of a heat-killed, heterologous yeast vaccine in outbred mice.","journal-title":"Vaccine"},{"key":"105_CR28","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1099\/jmm.0.033290-0","volume":"60","author":"M Liu","year":"2011","unstructured":"Liu M, Capilla J, Johansen ME, Alvarado D, Martinez M, Chen V, et al. Saccharomyces as a vaccine against systemic aspergillosis: \u2018the friend of man\u2019 a friend again? J Med Microbiol. 2011;60:1423\u201332.","journal-title":"J Med Microbiol"},{"key":"105_CR29","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/IAI.66.5.2342-2345.1998","volume":"66","author":"CR Zimmermann","year":"1998","unstructured":"Zimmermann CR, Johnson SM, Martens GW, White AG, Zimmer BL, Pappagianis D. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infect Immun. 1998;66:2342\u20135.","journal-title":"Infect Immun"},{"key":"105_CR30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1196\/annals.1406.016","volume":"1111","author":"SM Johnson","year":"2007","unstructured":"Johnson SM, Kerekes KM, Lunetta JM, Pappagianis D. Characteristics of the protective subcellular coccidioidal T27K vaccine. Ann N Y Acad Sci. 2007;1111:275\u201389.","journal-title":"Ann N Y Acad Sci"},{"key":"105_CR31","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1042\/BST0361478","volume":"36","author":"Y Kooyk van","year":"2008","unstructured":"van Kooyk Y. C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem Soc Trans. 2008;36:1478\u201381.","journal-title":"Biochem Soc Trans"},{"key":"105_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2012.06492.x","volume":"1253","author":"GA Rabinovich","year":"2012","unstructured":"Rabinovich GA, van Kooyk Y, Cobb BA. Glycobiology of immune responses. Ann N Y Acad Sci. 2012;1253:1\u201315.","journal-title":"Ann N Y Acad Sci"},{"key":"105_CR33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.coi.2012.04.007","volume":"24","author":"S Leibundgut-Landmann","year":"2012","unstructured":"\u2022\u2022 Leibundgut-Landmann S, W\u00fcthrich M, Hohl TM. Immunity to fungi. Cur Opin Immunol. 2012;24:449\u201358. This paper examines pathways of fungal innate immune activation and fungicidal mechanisms, signaling pathways that lead to induction of adaptive immunity, and strategies for development of fungal vaccines.","journal-title":"Cur Opin Immunol"},{"key":"105_CR34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20050749","volume":"202","author":"A Torosantucci","year":"2005","unstructured":"Torosantucci A, Bromuro C, Chiani P, De Bernardis F, Berti F, Galli C, et al. A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med. 2005;202:597\u2013606.","journal-title":"J Exp Med"},{"key":"105_CR35","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.vaccine.2009.12.021","volume":"28","author":"D Pietrella","year":"2010","unstructured":"Pietrella D, Rachini A, Torosantucci A, Chiani P, Brown AJ, Bistoni F, et al. A beta-glucan-conjugate vaccine and anti-\u03b2-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. Vaccine. 2010;28:1717\u201325.","journal-title":"Vaccine"},{"key":"105_CR36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cyto.2011.08.031","volume":"58","author":"S Vautier","year":"2012","unstructured":"\u2022 Vautier S, MacCallum DM, Brown GD. C-type lectin receptors and cytokines in fungal immunity. Cytokine. 2012;58:89\u201399. An excellent review of the C-type lectins, their influence on cytokine production and subsequent immune responses in antifungal immunity.","journal-title":"Cytokine"},{"key":"105_CR37","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.vaccine.2010.12.119","volume":"29","author":"M Liu","year":"2011","unstructured":"Liu M, Clemons KV, Bigos M, Medovarska I, Brummer E, Stevens DA. Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection. Vaccine. 2011;29:1745\u201353.","journal-title":"Vaccine"},{"key":"105_CR38","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1172\/JCI43984","volume":"121","author":"M W\u00fcthrich","year":"2011","unstructured":"\u2022\u2022 W\u00fcthrich M, Gern B, Hung CY, Ersland K, Rocco N, Pick-Jacobs J, et al. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest. 2011;121:554\u201368. The authors present a cogent argument for the critical need of activated Th17 cells for a protective immune response to Coccidioides and other dimorphic fungal infections of the respiratory system.","journal-title":"J Clin Invest"},{"key":"105_CR39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.4049\/jimmunol.1100921","volume":"187","author":"M W\u00fcthrich","year":"2011","unstructured":"W\u00fcthrich M, Hung CY, Gern BH, Pick-Jacobs JC, Galles KJ, Filutowicz HI, et al. A TCR transgenic mouse reactive with multiple systemic dimorphic fungi. J Immunol. 2011;187:1421\u201331.","journal-title":"J Immunol"},{"key":"105_CR40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev-immunol-020711-074958","volume":"30","author":"M Wuthrich","year":"2012","unstructured":"Wuthrich M, Deepe Jr GS, Klein B. Adaptive immunity to fungi. Annu Rev Immunol. 2012;30:115\u201348.","journal-title":"Annu Rev Immunol"},{"key":"105_CR41","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/IAI.01139-10","volume":"79","author":"A Kamei","year":"2011","unstructured":"Kamei A, Coutinho-Sledge YS, Goldberg JB, Priebe GP, Pier GB. Mucosal vaccination with a multivalent, live-attenuated vaccine induces multi-factorial immunity against Pseudomonas aeruginosa acute lung infection. Infect Immun. 2011;79:1289\u201399.","journal-title":"Infect Immun"},{"key":"105_CR42","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/IAI.00459-09","volume":"77","author":"J Xue","year":"2009","unstructured":"Xue J, Chen X, Selby D, Hung CY, Yu JJ, Cole GT. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB\/c mice against coccidioidomycosis. Infect Immun. 2009;77:3196\u2013208.","journal-title":"Infect Immun"},{"key":"105_CR43","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/IAI.05726-11","volume":"79","author":"CY Hung","year":"2011","unstructured":"\u2022 Hung CY, Gonzalez A, W\u00fcthrich M, Klein BS, Cole GT. Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17). Infect Immun. 2011;79:4511\u201322. This paper summarizes features of vaccine immunity to coccidioidomycosis in mice vaccinated with a live, genetically-engineered mutant strain of Coccidioides.","journal-title":"Infect Immun"},{"key":"105_CR44","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.vaccine.2012.04.084","volume":"30","author":"CY Hung","year":"2012","unstructured":"\u2022 Hung CY, Hurtgen BJ, Bellecourt M, Sanderson SD, Morgan EL, Cole GT. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection. Vaccine. 2012;30:4681\u201390. The authors present evidence that the EP67 adjuvant enhances protection of a live Coccidioides vaccine by augmentation of T-cell immunity, especially through Th1- and Th17-mediated host responses to infection.","journal-title":"Vaccine"},{"key":"105_CR45","unstructured":"Hung C-Y, Castro-Lopez N, Cole GT. Diverse pulmonary T cell subsets of vaccinated and non-vaccinated C57BL\/6 mice produce immunomodulatory IL-10 during Coccidioides infection [abstract]. 112th General Meeting, American Society for Microbiology, San Francisco, CA, 16\u201319 June 2012."},{"key":"105_CR46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1165\/rcmb.2009-0047TR","volume":"43","author":"G Balamayooran","year":"2010","unstructured":"Balamayooran G, Batra S, Fessler MB, Happel KI, Jeyaseelan S. Mechanisms of neutrophil accumulation in the lungs against bacteria. Am J Resp Cell Mol Biol. 2010;43:5\u201316.","journal-title":"Am J Resp Cell Mol Biol"},{"key":"105_CR47","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/infdis\/153.5.933","volume":"153","author":"CL Frey","year":"1986","unstructured":"Frey CL, Drutz DJ. Influence of fungal surface components on the interaction of Coccidioides immitis with polymorphonuclear neutrophils. J Infect Dis. 1986;153:933\u201343.","journal-title":"J Infect Dis"},{"key":"105_CR48","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/clinids\/4.3.656","volume":"4","author":"RM Echols","year":"1982","unstructured":"Echols RM, Palmer DL, Long GW. Tissue eosinophilia in human coccidioidomycosis. Rev Infect Dis. 1982;4:656\u201364.","journal-title":"Rev Infect Dis"},{"key":"105_CR49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.micpath.2010.11.006","volume":"50","author":"A Gonzalez","year":"2011","unstructured":"Gonzalez A, Hung CY, Cole GT. Coccidioides releases a soluble factor that suppresses nitric oxide production by murine primary macrophages. Microb Pathogen. 2011;50:100\u20138.","journal-title":"Microb Pathogen"},{"key":"105_CR50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.micpath.2011.03.013","volume":"51","author":"A Gonzalez","year":"2011","unstructured":"Gonzalez A, Hung CY, Cole GT. Nitric oxide synthase activity has limited influence on the control of Coccidioides infection in mice. Microb Pathogen. 2011;51:161\u20138.","journal-title":"Microb Pathogen"},{"key":"105_CR51","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1128\/IAI.65.4.1307-1312.1997","volume":"65","author":"K Kawakami","year":"1997","unstructured":"Kawakami K, Tohyama M, Qifeng X, Saito A. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect Immun. 1997;65:1307\u201312.","journal-title":"Infect Immun"},{"key":"105_CR52","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-2249.1999.00822.x","volume":"115","author":"T Chinen","year":"1999","unstructured":"Chinen T, Qureshi MH, Koguchi Y, Kawakami K. Candida albicans suppresses nitric oxide (NO) production by interferon-gamma (IFN-\u03b3) and lipopolysaccharide (LPS)-stimulated murine peritoneal macrophages. Clin Exp Immunol. 1999;115:491\u20137.","journal-title":"Clin Exp Immunol"},{"key":"105_CR53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1438-4221(01)80003-5","volume":"290","author":"K Schroppel","year":"2001","unstructured":"Schroppel K, Kryk M, Herrmann M, Leberer E, Rollinghoff M, Bogdan C. Suppression of type 2 NO-synthase activity in macrophages by Candida albicans. Int J Med Microbiol. 2001;290:659\u201368.","journal-title":"Int J Med Microbiol"},{"key":"105_CR54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0008-8749(02)00576-2","volume":"218","author":"A Flavia-Popi","year":"2002","unstructured":"Flavia-Popi A, Daniel Lopes J, Mariano M. GP43 from Paracoccidioides brasiliensis inhibits macrophage functions. An evasion mechanism of the fungus. Cell Immunol. 2002;218:87\u201394.","journal-title":"Cell Immunol"},{"key":"105_CR55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1348-0421.2008.00019.x","volume":"52","author":"G Xiao","year":"2008","unstructured":"Xiao G, Miyazato A, Inden K, Nakamura K, Shiratori K, Nakagawa K, et al. Cryptococcus neoformans inhibits nitric oxide synthesis caused by CpG-oligodeoxynucleotide-stimulated macrophages in a fashion independent of capsular polysaccharides. Microbiol Immunol. 2008;52:171\u20139.","journal-title":"Microbiol Immunol"},{"key":"105_CR56","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.micpath.2011.08.003","volume":"51","author":"A Gonzalez","year":"2011","unstructured":"Gonzalez A, Hung CY, Cole GT. Absence of phagocyte NADPH oxidase 2 leads to severe inflammatory response in lungs of mice infected with Coccidioides. Microb Pathogen. 2011;51:432\u201341.","journal-title":"Microb Pathogen"},{"key":"105_CR57","doi-asserted-by":"crossref","first-page":"71e","DOI":"10.1186\/1471-2180-11-71","volume":"11","author":"DA Margolis","year":"2011","unstructured":"Margolis DA, Viriyakosol S, Fierer J, Kirkland TN. The role of reactive oxygen intermediates in experimental coccidioidomycosis in mice. BMC Microbiol. 2011;11:71e.","journal-title":"BMC Microbiol"},{"key":"105_CR58","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-06-290171","volume":"117","author":"KD Metzler","year":"2011","unstructured":"Metzler KD, Fuchs TA, Nauseef WM, Reumaux D, Roesler J, Schulze I, et al. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood. 2011;117:953\u20139.","journal-title":"Blood"},{"key":"105_CR59","doi-asserted-by":"crossref","first-page":"849136","DOI":"10.1155\/2012\/849136","volume":"2012","author":"T Kirchner","year":"2012","unstructured":"\u2022 Kirchner T, Moller S, Klinger M, Solbach W, Laskay T, Behnen M. The impact of various reactive oxygen species on the formation of neutrophil extracellular traps. Mediat Inflamm. 2012. doi: 10.1155\/2012\/849136 . The authors discuss the requirement of NADPH oxidase and myeloperoxidase but not superoxide dismutase activity for the release of NETs.","journal-title":"Mediat Inflamm"},{"key":"105_CR60","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1462-5822.2005.00659.x","volume":"8","author":"CF Urban","year":"2006","unstructured":"Urban CF, Reichard U, Brinkmann V, Zvchlinsky A. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol. 2006;8:668\u201376.","journal-title":"Cell Microbiol"},{"key":"105_CR61","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jaci.2011.01.021","volume":"127","author":"M Bianchi","year":"2011","unstructured":"Bianchi M, Niemiec MJ, Siler U, Urban CF, Reichenbach J. Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent. J Allergy Clin Immunol. 2011;127:1243\u201352.","journal-title":"J Allergy Clin Immunol"},{"key":"105_CR62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/ar3773","volume":"14","author":"I Neeli","year":"2012","unstructured":"Neeli I, Radic M. Knotting the NETs: analyzing histone modifications in neutrophil extracellular traps. Arthritis Res Ther. 2012;14:115.","journal-title":"Arthritis Res Ther"},{"key":"105_CR63","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20030109","volume":"197","author":"M W\u00fcthrich","year":"2003","unstructured":"W\u00fcthrich M, Filutowicz HI, Warner T, Deepe GS, Klein BS. Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells. J Exp Med. 2003;197:1405\u201316.","journal-title":"J Exp Med"},{"key":"105_CR64","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1086\/502972","volume":"193","author":"J Fierer","year":"2006","unstructured":"Fierer J, Waters C, Walls L. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice. J Infect Dis. 2006;193:1323\u201331.","journal-title":"J Infect Dis"},{"key":"105_CR65","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1172\/JCI58762","volume":"122","author":"SG Nanjappa","year":"2012","unstructured":"\u2022\u2022 Nanjappa SG, Heninger E, W\u00fcthrich M, Sullivan T, Klein B. Protective antifungal memory CD8+ T cells are maintained in the absence of CD4+ T cell help and cognate antigen in mice. J Clin Invest. 2012;122:987\u201399. The authors demonstrate in a mouse model that immunization with a live vaccine against a dimorphic fungal pathogen results in production of antifungal CD8+ T cells which are maintained in the absence of CD4+ T cells without loss of function or number for at least 6 months and protect against infection.","journal-title":"J Clin Invest"},{"key":"105_CR66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jinf.2011.07.006","volume":"63","author":"CA Duplessis","year":"2011","unstructured":"Duplessis CA, Tilley D, Bavaro M, Hale B, Holland SM. Two cases illustrating successful adjunctive interferon-\u03b3 immunotherapy in refractory disseminated coccidioidomycosis. J Infect. 2011;63:223\u20138.","journal-title":"J Infect"},{"key":"105_CR67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1574-695X.2011.00851.x","volume":"63","author":"AS Nishikaku","year":"2011","unstructured":"Nishikaku AS, Molina RFS, Albe BP, Cunha CDS, Scavone R, Pizzo CRP, et al. Immunolocalization of IFN-gamma in the lesions of resistant and susceptible mice to Paracoccidioides brasiliensis infection. FEMS Immunol Med Microbiol. 2011;63:281\u20138.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"105_CR68","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.4049\/jimmunol.162.12.7389","volume":"162","author":"R Allend\u00f6rfer","year":"1999","unstructured":"Allend\u00f6rfer R, Brunner GD, Deepe GS. Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol. 1999;162:7389\u201396.","journal-title":"J Immunol"},{"key":"105_CR69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/cid\/ciq215","volume":"52","author":"DC Vinh","year":"2011","unstructured":"Vinh DC, Schwartz B, Hsu AP, Miranda DJ, Valdez PA, Fink D, et al. Interleukin-12 receptor-\u03b21 deficiency predisposing to disseminated coccidioidomycosis. Clin Infect Dis. 2011;52:99\u2013102.","journal-title":"Clin Infect Dis"},{"key":"105_CR70","doi-asserted-by":"crossref","first-page":"e6420","DOI":"10.1371\/journal.pone.0006420","volume":"4","author":"DM MacCallum","year":"2009","unstructured":"MacCallum DM, Castillo L, Brown AJP, Gow NAR, Odds FC. Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. PLoS One. 2009;4:e6420.","journal-title":"PLoS One"},{"key":"105_CR71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","volume":"29","author":"W Ouyang","year":"2011","unstructured":"\u2022 Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29:71\u2013109. The authors discuss the importance of the family of IL-10 cytokines in facilitating the tissue-healing process caused by infection and inflammation.","journal-title":"Annu Rev Immunol"},{"key":"105_CR72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13693780410001687349","volume":"42","author":"GT Cole","year":"2004","unstructured":"Cole GT, Xue JM, Okeke CN, Tarcha EJ, Basrur V, Schaller RA, et al. A vaccine against coccidioidomycosis is justified and attainable. Med Mycol. 2004;42:189\u2013216.","journal-title":"Med Mycol"},{"key":"105_CR73","unstructured":"Hurtgen BJ, Hung C-Y, Cole GT. A human T-cell epitope-driven vaccine against San Joaquin Valley Fever [abstract]. 111th General Meeting, American Society for Microbiology, New Orleans, LA, 21\u201324 May 2011."},{"key":"105_CR74","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/IAI.74.1.516-527.2006","volume":"74","author":"EJ Tarcha","year":"2006","unstructured":"Tarcha EJ, Basrur V, Hung CY, Gardner MJ, Cole GT. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice. Infect Immun. 2006;74:516\u201327.","journal-title":"Infect Immun"},{"key":"105_CR75","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1128\/IAI.00961-06","volume":"74","author":"EJ Tarcha","year":"2006","unstructured":"Tarcha EJ, Basrur V, Hung CY, Gardner MJ, Cole GT. Multivalent recombinant protein vaccine against coccidioidomycosis. Infect Immun. 2006;74:5802\u201313.","journal-title":"Infect Immun"},{"key":"105_CR76","doi-asserted-by":"crossref","unstructured":"\u2022 Hurtgen BJ, Hung C-Y, Ostroff GR, Levitz SM, Cole GT. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against coccidioidomycosis. Infect Immun. 2012. Forthcoming. doi:10.1128\/IAI.00566-12. The authors describe a protein vaccine consisting of computationally selected and validated T-cell epitopes fused with leader and spacer peptides proposed to optimize epitope processing and presentation to T cell receptors.","DOI":"10.1128\/IAI.00566-12"},{"key":"105_CR77","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/bioinformatics\/17.12.1236","volume":"17","author":"H Singh","year":"2001","unstructured":"Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics. 2001;17:1236\u20137.","journal-title":"Bioinformatics"},{"key":"105_CR78","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.4049\/jimmunol.167.12.7119","volume":"167","author":"TG Forsthuber","year":"2001","unstructured":"Forsthuber TG, Shive CL, Wienhold W, De Graaf K, Spack EG, Sublett R, et al. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. J Immunol. 2001;167:7119\u201325.","journal-title":"J Immunol"},{"key":"105_CR79","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4049\/jimmunol.1101663","volume":"187","author":"RN Germain","year":"2011","unstructured":"Germain RN. Uncovering the role of invariant chain in controlling MHC class II antigen capture. J Immunol. 2011;187:1073\u20135.","journal-title":"J Immunol"},{"key":"105_CR80","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","volume":"168","author":"B Livingston","year":"2002","unstructured":"Livingston B, Crimi C, Newman M, Higashimoto Y, Appella E, Sidney J, et al. A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J Immunol. 2002;168:5499\u2013506.","journal-title":"J Immunol"},{"key":"105_CR81","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00005-010-0067-0","volume":"58","author":"DS Rosa","year":"2010","unstructured":"Rosa DS, Ribeiro SP, Cunha-Neto E. CD4+ T cell epitope discovery and rational vaccine design. Arch Immunol Ther Exp. 2010;58:121\u201330.","journal-title":"Arch Immunol Ther Exp"},{"key":"105_CR82","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/IAI.69.5.2878-2887.2001","volume":"69","author":"K Li","year":"2001","unstructured":"Li K, Yu J-J, Hung CY, Lehmann PF, Cole GT. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice. Infect Immun. 2001;69:2878\u201387.","journal-title":"Infect Immun"},{"key":"105_CR83","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1128\/IAI.71.6.3010-3019.2003","volume":"71","author":"N Delgado","year":"2003","unstructured":"Delgado N, Xue J, Yu JJ, Hung CY, Cole GT. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis. Infect Immun. 2003;71:3010\u20139.","journal-title":"Infect Immun"},{"key":"105_CR84","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2147\/IJN.S30197","volume":"7","author":"N Hanagata","year":"2012","unstructured":"Hanagata N. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system. Int J Nanomed. 2012;7:2181\u201395.","journal-title":"Int J Nanomed"},{"key":"105_CR85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/nat.2012.0340","volume":"22","author":"AM Krieg","year":"2012","unstructured":"Krieg AM. CpG still rocks! Update on an accidental drug. Nucleic Acid Ther. 2012;22:77\u201389.","journal-title":"Nucleic Acid Ther"},{"key":"105_CR86","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1016\/j.vaccine.2010.10.008","volume":"28","author":"EL Morgan","year":"2010","unstructured":"Morgan EL, Thoman ML, Sanderson SD, Phillips JA. A novel adjuvant for vaccine development in the aged. Vaccine. 2010;28:8275\u20139.","journal-title":"Vaccine"},{"key":"105_CR87","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.intimp.2008.01.031","volume":"8","author":"GV Hegde","year":"2008","unstructured":"Hegde GV, Meyers-Clark E, Joshi SS, Sanderson SD. A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells. Int Immunopharmacol. 2008;8:819\u201327.","journal-title":"Int Immunopharmacol"},{"key":"105_CR88","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.vaccine.2009.02.105","volume":"27","author":"MJ Duryee","year":"2009","unstructured":"Duryee MJ, Bevins RA, Reichel CM, Murray JE, Dong Y, Thiele GM, et al. Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines. Vaccine. 2009;27:2981\u20138.","journal-title":"Vaccine"},{"key":"105_CR89","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1567-5769(02)00260-6","volume":"3","author":"SD Sanderson","year":"2003","unstructured":"Sanderson SD, Cheruku SR, Padmanilayam MP, Vennerstrom JL, Thiele GM, Palmatier MI, et al. Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant. Int Immunopharmacol. 2003;3:137\u201346.","journal-title":"Int Immunopharmacol"},{"key":"105_CR90","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.vaccine.2009.10.029","volume":"28","author":"EL Morgan","year":"2009","unstructured":"Morgan EL, Morgan BN, Stein EA, Vitrs EL, Thoman ML, Sanderson SD, et al. Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design. Vaccine. 2009;28:463\u20139.","journal-title":"Vaccine"},{"key":"105_CR91","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/0929867013373156","volume":"8","author":"SM Taylor","year":"2001","unstructured":"Taylor SM, Sherman SA, Kirnarsky L, Sanderson SD. Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations. Curr Med Chem. 2001;8:675\u201384.","journal-title":"Curr Med Chem"},{"key":"105_CR92","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S1567-5769(01)00141-2","volume":"1","author":"SM Vogen","year":"2001","unstructured":"Vogen SM, Paczkowski NJ, Kirnarsky L, Short A, Whitmore JB, Sherman SA, et al. Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation. Int Immunopharmacol. 2001;1:2151\u201362.","journal-title":"Int Immunopharmacol"},{"key":"105_CR93","doi-asserted-by":"crossref","first-page":"e00164","DOI":"10.1128\/mBio.00164-10","volume":"1","author":"H Huang","year":"2010","unstructured":"Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded \u03b2-glucan particles. MBio. 2010;1:e00164\u201310.","journal-title":"MBio"},{"key":"105_CR94","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4049\/jimmunol.1200603","volume":"189","author":"H Huang","year":"2012","unstructured":"\u2022 Huang H, Ostroff GR, Lee CK, Agarwal S, Ram S, Rice PA, et al. Relative contributions of Dectin-1 and complement to immune responses to particulate beta-glucans. J Immunol. 2012;189:312\u20137. The authors suggest a dominant role for complement and a redundant role for Dectin-1 in both phagocytosis of GPs and CD4+ Th17-biased immune response after GP-based vaccination.","journal-title":"J Immunol"},{"key":"105_CR95","unstructured":"Hurtgen BJ, Castro-Lopez N, Hung C-Y, Cole GT. Heterogeneity of immune response of vaccinated HLA-DR4 (DRB1*0401) transgenic mice to coccidioidomycosis [abstr]. 112th General Meeting, American Society for Microbiology, San Francisco, CA, 16\u201319 June 2012."},{"key":"105_CR96","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1128\/CMR.17.4.804-839.2004","volume":"17","author":"RA Cox","year":"2004","unstructured":"Cox RA, Magee DM. Coccidioidomycosis: host response and vaccine development. Clin Microbiol Rev. 2004;17:804\u201339.","journal-title":"Clin Microbiol Rev"},{"key":"105_CR97","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1537","volume":"5","author":"JE Cutler","year":"2007","unstructured":"Cutler JE, Deepe GS, Klein BS. Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol. 2007;5:13\u201328.","journal-title":"Nat Rev Microbiol"},{"key":"105_CR98","first-page":"467","volume":"33","author":"RG Iannitti","year":"2012","unstructured":"Iannitti RG, Carvalho A, Romani L. From memory to antifungal vaccine design. Trends Microbiol. 2012;33:467\u201374.","journal-title":"Trends Microbiol"},{"key":"105_CR99","first-page":"299","volume":"28","author":"W Magliani","year":"2005","unstructured":"Magliani W, Conti S, Arseni S, Salati A, Ravanetti L, Maffei DL, et al. Antibody-mediated protective immunity in fungal infections. New Microbiol. 2005;28:299\u2013309.","journal-title":"New Microbiol"},{"key":"105_CR100","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1084\/jem.20100034","volume":"207","author":"RR Rapaka","year":"2010","unstructured":"Rapaka RR, Ricks DM, Alcorn JF, Chen K, Khader SA, Zheng M, et al. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J Exp Med. 2010;207:2907\u201319.","journal-title":"J Exp Med"},{"key":"105_CR101","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","volume":"11","author":"A Casadevall","year":"2012","unstructured":"\u2022\u2022 Casadevall A, Pirofski LA. Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe. 2012;11:447\u201356. This paper reviews evidence that fungal-specific antibodies can alter the course of mycoses to the benefit or detriment of the host.","journal-title":"Cell Host Microbe"},{"key":"105_CR102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2011.12.005","volume":"15","author":"A Cassone","year":"2012","unstructured":"\u2022 Cassone A, Casadevall A. Recent progress in vaccines against fungal diseases. Curr Opin Microbiol. 2012;15:1\u20137. Discussion of progress in the generation of vaccines against certain opportunistic fungal infections, with a review of those vaccines currently in clinical trial.","journal-title":"Curr Opin Microbiol"},{"key":"105_CR103","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nri3085","volume":"11","author":"R Rappuoli","year":"2011","unstructured":"Rappuoli R, Mandl CW, Black S, De Gregorio E. Vaccines for the twenty-first century society. Nat Rev Immunol. 2011;11:865\u201372.","journal-title":"Nat Rev Immunol"},{"key":"105_CR104","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/icb.2010.117","volume":"89","author":"CK Baumgartner","year":"2011","unstructured":"Baumgartner CK, Malherbe LP. Antigen-driven T-cell repertoire selection during adaptive immune responses. Immunol Cell Biol. 2011;89:54\u20139.","journal-title":"Immunol Cell Biol"}],"container-title":["Current Fungal Infection Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12281-012-0105-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12281-012-0105-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12281-012-0105-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T20:55:15Z","timestamp":1687726515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12281-012-0105-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,18]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1007\/s12281-012-0105-y","relation":{},"ISSN":["1936-3761","1936-377X"],"issn-type":[{"value":"1936-3761","type":"print"},{"value":"1936-377X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,18]]}}}